Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Momelotinib

Selective inhibitor of JAK1 and JAK2 kinases including the JAK2 V617F mutant
 
ENZ-CHM197-0001 1 mg 53.00 USD
 
ENZ-CHM197-0005 5 mg 97.00 USD
Do you need bulk/larger quantities?
 
Using ATP kinase assays, the IC50 values for CYT387 are a follows - JAK1 (11nM), JAK2, (18nM), JAK2 V617F (23nM) JAK3 (155nM), and TYK2 (17nM). In testing kinase arrays, CYT387 also had activity (defined as an IC50 < 100nM) detected against CDK2/cyclin A, MAPK8 (JNK1), PRKCN (PKD3), PRKD1 (PKCμ), ROCK2, and TBK1 kinase as well.

Product Specification

Alternative Name:CYT 387, N-​​(cyanomethyl)​-​​4-​​[2-​​[[4-​​(4-​​morpholinyl)​phenyl]​amino]​-​​4-​​pyrimidinyl]​-​benzamide
 
Formula:C23H22N6O2
 
MW:414.5
 
CAS:1056634-68-4
 
Purity:≥97% (HPLC)
 
Identity:Determined by EM-MS, NMR
 
Appearance:Orange powder.
 
Solubility:Soluble in DMSO (>20mM).
 
Shipping:Ambient
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
ENZ-CHM197 structure
Please mouse over
ENZ-CHM197 structure

Related Literature

Brochures
Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,